title: Interferon-free hepatitis C treatment: one pill to fit all?
authors.affiliation: Centre for Population Health, Burnet Institute, Melbourne, VIC 3004, Australia; Department of Infectious Diseases, The Alfred Hospital, Melbourne, VIC, Australia; Department of Epidemiology and Preventative Medicine, Monash University, VIC, Australia. Electronic address: hellard@burnet.edu.au.
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Hellard
authors.affiliation: Centre for Population Health, Burnet Institute, Melbourne, VIC 3004, Australia; Department of Infectious Diseases, The Alfred Hospital, Melbourne, VIC, Australia; Department of Epidemiology and Preventative Medicine, Monash University, VIC, Australia.
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Doyle
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012254:Ribavirin / Q000008:administration & dosage*; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*; D012324:RNA-Dependent RNA Polymerase
chemical_list: D000998:Antiviral Agents; D011480:Protease Inhibitors; D012254:Ribavirin; D000069474:Sofosbuvir; D014542:Uridine Monophosphate; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase